 Connection
Stephen Humphries to Bleomycin
This is a "connection" page, showing publications Stephen Humphries has written about Bleomycin.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.303 |
|
|
|
-
Wang Y, Hennessy C, Dobrinskikh E, Humphries SM, Hatakka K, Ackert-Bicknell CL, Godfrey DA, Kelada SNP, Keele GR, Cardwell J, Peljto A, Clouthier DE, Yang IV, Schwartz DA. Genes, other than Muc5b, are associated with bleomycin-induced lung injury. Commun Biol. 2026 May 12; 9(1).
Score: 0.212
-
Cooley JC, Penick SK, Wilson JA, Javkhlan N, Foster DG, Edelman BL, Schott CA, Humphries SM, Lynch DA, Schwartz DA, Riches DWH, Redente EF. Nintedanib increases BCL-2 in fibrotic fibroblasts, enhancing ABT-199 apoptosis and fibrosis resolution. Am J Respir Cell Mol Biol. 2026 Aug 01; 74(8):1103-1113.
Score: 0.054
-
Redente EF, Black BP, Backos DS, Bahadur AN, Humphries SM, Lynch DA, Tuder RM, Zemans RL, Riches DWH. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice. Am J Respir Cell Mol Biol. 2021 06; 64(6):669-676.
Score: 0.038
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|